Latest News

Iron chelation drug used to treat rare, devastating neurodegenerative disease in children

A promising pilot study of deferiprone for the treatment of the neurodegenerative disorder, PKAN, leads to an international trial with potential implications for Parkinson?s and other neurodegenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emergency department treatment for opioid addiction better than referrals

  • Impulsive, angry personalities more prone to aggressive driving, accidents, study finds

  • Framing time in days instead of years could spur action toward goals

  • Family break-up linked to heightened risk of psychosomatic problems in teens

  • Early separation of cow and calf has long-term effects on social behavior

  • Should voting be compulsory or should we have a right not to vote?

  • Dyslexic children do not detect stressed syllables well while listening to words

  • A glitch in the recycling: Study identifies key factor in the neural death that causes Parkinson's disease

  • Women show persistent memory impairment after concussion

  • Discovery of an unexpected function of a protein linked to neurodegenerative diseases

  •